DLP-115-Top.jpg

DLP-119 – Olanzapine 3 month Formulation

DLP-119 is a 3 month formulation of Olanzapine. The product is using Delpor’s ProzorTM technology and the medication is released from Delpor’s subcutaneous implant device. The system enables zero order release kinetics and it is expected to maintain therapeutic levels of the drug during a period of 3 months after implantation.

Comments are closed.